Zhejiang Hisun Pharmaceutical (600267.SH): European Union revokes declaration that Taizhou factory does not comply with GMP regulations.

Zhejiang Hisun Pharmaceutical (600267.SH) announced that the European Union has revoked the "GMP Non-Compliance Declaration" for the company's Taizhou factory. The non-compliance declaration for the second phase project (factories Y20, Y36, Y37, Y38, and Y39) was revoked on October 17, 2025. After checking the official EU database, it is currently not possible to find any "GMP Non-Compliance Declaration" for the company's Taizhou factory. This means that the EU has lifted the non-compliance status for the company's Taizhou factory, which will have a positive impact on the company's products being sold in the EU market and other markets.